Defense World
05 Apr 2026, 08:47 UTC · 24w ago
Verdict
Headline takes no side. We score TWST +0.40 across five claims — moderately bullish.
+0.40moderately bullish
More positive than 59% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Twist Bioscience reported Q2 revenue of $103.70 million, beating the consensus estimate of $100.32 million and growing 16.9% year-over-year.
So whatA revenue beat with solid double-digit growth directly signals stronger-than-expected demand and business momentum, which is highly positive for a growth stock's valuation.
More positive than 97% of claims this week
EdgePoint Investment Group and William Blair Investment Management accumulated large stakes in Twist Bioscience, owning 4.08 million and 4.14 million shares worth $114.8 million and $116.5 million, respectively.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 85% of claims this week
The company reported Q2 EPS of ($0.50), missing analysts' consensus estimates of ($0.48) by $0.02.
More negative than 85% of claims this week
Analysts maintain a consensus 'Moderate Buy' on Twist Bioscience with a consensus price target of $46.50, while Guggenheim raised its target to $55 and Evercore raised its target to $52.
So whatUpward target revisions from major firms and a moderately bullish consensus provide a positive valuation framework that can attract incremental investor interest.
More positive than 69% of claims this week
Insiders sold a total of 49,190 shares of company stock valued at $2,285,695 over the last quarter.
More negative than 73% of claims this week
Which stocks this story touches
More positive than 59% of ticker scores this week
Strong institutional buying and multiple analyst upgrades/buy ratings outweigh a slight earnings miss and minor insider selling.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+230.2%
Price agrees with the score
$165.81 vs $50.21 close before publication (Apr 2) · not market-adjusted
TWST chart →